Roche

Roche Pharmaceuticals – Product Catalog (A–Z)

Actemra / RoActemra → Generic: tocilizumab → Indication: Rheumatoid arthritis, giant cell arteritis, systemic juvenile idiopathic arthritis, cytokine release syndrome (CRS) → Dose: IV infusion, SC injection

Alecensa → Generic: alectinib → Indication: ALK+ metastatic non–small cell lung cancer (NSCLC) → Dose: Capsules 150 mg

Avastin → Generic: bevacizumab → Indication: Colorectal, lung, renal, ovarian, cervical, glioblastoma (anti-VEGF) → Dose: IV infusion

CellCept → Generic: mycophenolate mofetil → Indication: Organ transplant immunosuppression → Dose: Tablets 250–500 mg; IV

Cotellic → Generic: cobimetinib → Indication: BRAF V600-mutated melanoma (with vemurafenib) → Dose: Tablets 20 mg

Cytovene / Valcyte → Generic: ganciclovir / valganciclovir → Indication: CMV infections in immunocompromised patients → Dose: Oral & IV forms

Erivedge → Generic: vismodegib → Indication: Advanced basal cell carcinoma (BCC) → Dose: Capsules 150 mg

Esbriet → Generic: pirfenidone → Indication: Idiopathic pulmonary fibrosis (IPF) → Dose: Capsules 267 mg; tablets 801 mg

Evrysdi → Generic: risdiplam → Indication: Spinal muscular atrophy (SMA) → Dose: Oral solution 0.75 mg/mL

Fuzeon → Generic: enfuvirtide → Indication: HIV (fusion inhibitor) → Dose: SC injection 90 mg bid

Gazyva / Gazyvaro → Generic: obinutuzumab → Indication: CLL, follicular lymphoma → Dose: IV infusion vials

Hemlibra → Generic: emicizumab → Indication: Hemophilia A (prophylaxis, with/without inhibitors) → Dose: SC injection 30–150 mg

Herceptin → Generic: trastuzumab → Indication: HER2+ breast & gastric cancer → Dose: IV infusion

Kadcyla → Generic: trastuzumab emtansine (T-DM1) → Indication: HER2+ breast cancer → Dose: IV infusion

Lucentis → Generic: ranibizumab → Indication: Wet AMD, diabetic macular edema, retinal vein occlusion → Dose: Intravitreal injection 0.3–0.5 mg

MabThera / Rituxan → Generic: rituximab → Indication: NHL, CLL, RA, GPA/MPA → Dose: IV infusion; SC formulation available

Ocrevus → Generic: ocrelizumab → Indication: Relapsing & primary progressive multiple sclerosis → Dose: IV infusion 300 mg/10 mL

Perjeta → Generic: pertuzumab → Indication: HER2+ breast cancer (with trastuzumab + chemo) → Dose: IV infusion

Phesgo → Generic: pertuzumab + trastuzumab + hyaluronidase → Indication: HER2+ breast cancer (fixed-dose SC combo) → Dose: Prefilled syringe/injector

Polivy → Generic: polatuzumab vedotin → Indication: Diffuse large B-cell lymphoma (with bendamustine + rituximab) → Dose: IV infusion

Pulmozyme → Generic: dornase alfa → Indication: Cystic fibrosis (mucolytic) → Dose: Nebulizer solution 2.5 mg

Rozlytrek → Generic: entrectinib → Indication: NTRK+ solid tumors, ROS1+ NSCLC → Dose: Capsules 100–200 mg

Tecentriq → Generic: atezolizumab → Indication: NSCLC, TNBC, bladder cancer, hepatocellular carcinoma (anti–PD-L1) → Dose: IV infusion 840–1200 mg

Tarceva → Generic: erlotinib → Indication: EGFR-mutated NSCLC, pancreatic cancer → Dose: Tablets 25–150 mg

Venclexta (co-marketed with AbbVie) → Generic: venetoclax → Indication: CLL, AML → Dose: Tablets 10–100 mg

Xeloda → Generic: capecitabine → Indication: Breast, colorectal, gastric cancer → Dose: Tablets 150 mg, 500 mg

Xofluza → Generic: baloxavir marboxil → Indication: Influenza treatment & prophylaxis → Dose: Tablets 20 mg, 40 mg